837 related articles for article (PubMed ID: 13679574)
1. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
3. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
Luttrell LM; Ferguson SS; Daaka Y; Miller WE; Maudsley S; Della Rocca GJ; Lin F; Kawakatsu H; Owada K; Luttrell DK; Caron MG; Lefkowitz RJ
Science; 1999 Jan; 283(5402):655-61. PubMed ID: 9924018
[TBL] [Abstract][Full Text] [Related]
5. Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor.
Burghi V; Paradis JS; Officer A; Adame-Garcia SR; Wu X; Matthees ESF; Barsi-Rhyne B; Ramms DJ; Clubb L; Acosta M; Tamayo P; Bouvier M; Inoue A; von Zastrow M; Hoffmann C; Gutkind JS
J Biol Chem; 2023 Nov; 299(11):105293. PubMed ID: 37774973
[TBL] [Abstract][Full Text] [Related]
6. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
7. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
Huet E; Boulay F; Barral S; Rabiet MJ
Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
[TBL] [Abstract][Full Text] [Related]
9. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
10. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
11. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
12. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
Charest PG; Bouvier M
J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
Singh M; Moniri NH
Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
[TBL] [Abstract][Full Text] [Related]
15. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
16. Low affinity of beta1-adrenergic receptor for beta-arrestins explains the resistance to agonist-induced internalization.
Shiina T; Nagao T; Kurose H
Life Sci; 2001 Apr; 68(19-20):2251-7. PubMed ID: 11358334
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
[TBL] [Abstract][Full Text] [Related]
18. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
[TBL] [Abstract][Full Text] [Related]
19. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
20. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
